All Companies

LLY

Eli Lilly & Co.

Pharmaceutical Preparations

$1,152.44updated Sep 18, 2026

Congressional trading profile for Eli Lilly & Co. (LLY), covering 53 disclosed transactions by 22 lawmakers.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Total Trades

53

Politicians Trading

22

Last Traded

Jul 10, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
Michael A. RulliRAug 7, 2026Jul 1, 2026Sell$1,001 - $15,000-3.30%
Michael A. RulliRAug 7, 2026Dec 2, 2025Sell$1,001 - $15,000+10.16%
Alan ArmstrongRJul 21, 2026Mar 27, 2026Sell$1,001 - $15,000+31.22%
Dan NewhouseRJul 17, 2026Jul 10, 2026Sell$1,001 - $15,000-3.04%
David TaylorRFeb 20, 2026Feb 9, 2026Sell$1,001 - $15,000+10.32%
David TaylorRFeb 2, 2026Jan 16, 2026Sell$1,001 - $15,000+10.98%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+9.04%
David TaylorRDec 19, 2025Dec 10, 2025Sell$1,001 - $15,000+15.98%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+12.67%
John BoozmanRDec 8, 2025Nov 21, 2025Sell$1,001 - $15,000+8.75%
Val T. HoyleDOct 10, 2025Sep 23, 2025Sell$1,001 - $15,000+54.28%
Val T. HoyleDSep 12, 2025May 6, 2025Sell$1,001 - $15,000+48.68%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+68.38%
Jonathan L. JacksonDAug 25, 2025May 21, 2025Sell$1,001 - $15,000+58.97%
Lisa C. McClainRAug 13, 2025Jul 16, 2025Sell$1,001 - $15,000+45.92%
Lisa C. McClainRAug 13, 2025Jun 9, 2025Sell$1,001 - $15,000+48.95%
Jonathan L. JacksonDJul 14, 2025Jun 3, 2025Sell$15,001 - $50,000+53.50%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$100,001 - $250,000+52.53%
Josh GottheimerDJun 11, 2025May 13, 2025Sell$1,001 - $15,000+54.47%
Gilbert Ray Cisneros, Jr.DJun 6, 2025May 30, 2025Sell$1,001 - $15,000+56.23%
Dan NewhouseRMay 16, 2025Apr 11, 2025Sell$1,001 - $15,000+57.35%
Tommy TubervilleRMay 15, 2025Apr 15, 2025Sell$15,001 - $50,000+52.20%
Josh GottheimerDMay 14, 2025Apr 9, 2025Sell$1,001 - $15,000+52.90%
Julie JohnsonDMay 14, 2025Apr 7, 2025Sell$1,001 - $15,000+59.24%
Bruce WestermanRMay 12, 2025Apr 21, 2025Sell$1,001 - $15,000+40.88%
Robert BresnahanRApr 28, 2025Apr 8, 2025Sell$1,001 - $15,000+58.69%
Josh GottheimerDApr 10, 2025Mar 10, 2025Sell$1,001 - $15,000+38.89%
Josh GottheimerDMar 6, 2025Feb 19, 2025Sell$1,001 - $15,000+32.92%
Ron WydenDFeb 21, 2025Feb 10, 2025Sell$50,001 - $100,000+32.64%
Josh GottheimerDFeb 10, 2025Jan 8, 2025Sell$1,001 - $15,000+46.39%